Market Need Target hospitals and physician offices treating heart failure to address rising costs and the high patient burden. Emphasize the potential to improve CHF management through rapid, non-invasive cardiac parameter measurement after FDA clearance.

Clinical Advantage Position the solution as a cost effective, scalable tool that enables more frequent evaluation and adjustment of treatments, aligning with cardiology workflows and potentially reducing readmissions and overall HF care costs.

Regulatory Readiness Highlight near-term FDA clearance as a differentiator for risk-averse buyers. Prepare to support pilots and validation studies to accelerate adoption in hospital and clinic settings.

Strategic Partnerships Explore collaborations with major medical device distributors and health systems, leveraging Vital Metrix’s biometric sensing capabilities to expand reach without large internal sales teams.

Funding and Validation Leverage the award recognition and existing modest funding to build credibility in proposals and to secure early adopters for case studies, showcasing measurable cost savings and patient outcomes.